Abstract
An easy approach for the synthesis of various 5-substituted-3-(prop-2-ynyl)dihydrofuran-2(3H)-ones is described. As a method of choice, Mannich aminomethylation of terminal alkynes is adopted. The reaction works well with acyclic and cyclic secondary amines and provides the desired products, with good to very good yields.
1 Introduction
Along with many other structures, γ-butyrolactones serve as important scaffolds for natural compounds [1, 2]. Structures bearing this fragment are widespread in nature, and a number of such molecules have been isolated so far [3–5]. Several compounds that may be of practical interest in pharmacology and medicine have been obtained from Gloiopeltis furcata, Aspergillus ustus, Gardenia sootepensis, Sinularia maxima, Salvia miltiorrhiza, and others [6–10]. Other examples include biologically important muricatacin [11], tornabeatins [12], and matairesinol [13] (Fig. 1).

Selected examples of natural products and pharmaceuticals based on the dihydrofuran-2(3H)-one scaffold.
Research on butanolide-containing structures is focused not only on isolation of natural compounds, but also on accessing the appropriate synthetic analogs [14–17]. Considerable interest in these compounds is explained by substantial biological activities that different dihydrofuran-2(3H)-one-based molecules possess including cytotoxic and antimicrobial activities [1, 3, 6–13, 18–20].
Moreover, there are several known experimental and approved drugs bearing a γ-butyrolactone fragment [21, 22] (Fig. 1). Considering all those mentioned above, it is obvious that the development of new methods for the synthesis of lactone-containing compounds is of a distinct interest.
Previously, we carried out numerous elaborations of the methods to get different functionally substituted dihydrofuran-2(3H)-ones [23]. Additionally, follow-up biological investigations of the latter have also been performed to reveal antibacterial activity of the synthesized compounds [24].
Mannich aminomethylation reactions are known to be widely used in fine organic synthesis [25, 26], but there are not many reports on the application of this method in the chemistry of lactones [27–29].
2 Results and discussion
To expand the library of potentially bioactive dihydrofuran-2(3H)-ones and to develop new methods for the synthesis of polyfunctionalized butanolides, we chose 5-substituted-3-(prop-2-ynyl)dihydrofuran-2(3H)-ones as an object for research and studied the aminomethylation of the terminal alkyne group by the Mannich reaction. At first, appropriate starting materials 1 were synthesized according to a known procedure [23]. Afterward, syntheses of target compounds 3a–l were carried out and optimal conditions providing high yields of products were determined (Scheme 1). The interaction of propynylbutanolides 1 with various secondary amines (e.g. dialkylamines, morpholine, piperidine) and paraformaldehyde in the presence of catalytic amounts of CuCl2 leads to the introduction of the aminomethyl fragment (Table 1).

Synthesis of 3a–l. (i) 1 (1.0 equiv.), amine (1.5 equiv.), paraformaldehyde (1.4 equiv.), CuCl2 (8.5 mol%), dioxane, 95 °C, 8 h.
Synthesis of 3a–l.

aYields of isolated products.
Moreover, it was established that the reaction of aminomethylation proceeds selectively at the triple bond and, irrespective of the nature of the used amine, provides high yields of the target products.
3 Conclusion
In conclusion, a general method for the synthesis of new dihydrofuran-2(3H)-ones has been elaborated. To transform initial γ-butyrolactones bearing an ethynyl group in the side chain, the Mannich aminomethylation method was used. As a result, a new functional group was successfully introduced into the molecule, with the triple bond remaining unchanged. All compounds were synthesized, with good to very good yields. Our future studies will be directed toward investigations on the biological activity of the synthesized compounds.
4 Experimental section
4.1 General
All chemicals are commercially available and were used without further purification. Thin layer chromatography (TLC) was performed with Silufol UV-254 plates using mixture of AcOH, MeOH, and C6H6 (in a ratio of 1:1:4) as eluent, and subsequent development was done by iodine vapor. 1H NMR data were recorded on a Varian Mercury-300 (300 MHz) spectrometer in [D6]DMSO. All chemical shifts are given in parts per million. Peak characterization: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet. Elemental analyses were performed with a Leco Mikroanalysator – TrueSpec CHNS Micro. Melting points of appropriate oxalate salts were determined on a Boetius Micro heating table and are not corrected.
4.2 General procedure for the synthesis of 3a–l
An oven-dried flask was filled with initial lactone 1 (0.035 mol), the appropriate secondary amine (0.053 mol), 1.6 g of paraformaldehyde (0.05 mol), 0.4 g of CuCl2 (8.5 mol%), and anhydrous 1,4-dioxane (55 mL). The mixture was stirred at 95–100 °C for 8 h. Afterward, the reaction was cooled to room temperature, and the solvent was distilled off under vacuum. The residue was acidified with hydrochloric acid to pH 2–3 and extracted with ether. The aqueous layer was subsequently alkalized with ammonia solution to pH 7–8 and again extracted with ether. The combined organic phases were washed with water and dried over anhydrous magnesium sulfate. After removal of the solvent, the residue was distilled to give the desired products.
4.2.1 3-(4-(Diethylamino)but-2-ynyl)-5-pentyldihydrofuran-2(3H)-one (3a)
Yield 79%, Rf = 0.40, m.p. (oxalate salt) 103–105 °C, b.p. 160–161 °C/1 mmHg. –
4.2.2 3-(4-Morpholinobut-2-ynyl)-5-pentyldihydrofuran-2(3H)-one (3b)
Yield 68%, Rf = 0.56, m.p. (oxalate salt) 132–134 °C, b.p. 189–190 °C/1 mmHg. –
4.2.3 3-(4-(Diethylamino)but-2-ynyl)-5-hexyldihydrofuran-2(3H)-one (3c)
Yield 75%, Rf = 0.67, m.p. (oxalate salt) 65–67 °C, b.p. 181–182 °C/2 mmHg. –
4.2.4 3-(4-(Diethylamino)but-2-ynyl)-5-(propoxymethyl)dihydrofuran-2(3H)-one (3d)
Yield 73%, Rf = 0.51, m.p. (oxalate salt) 81–82 °C, b.p. 154–155 °C/1 mmHg. –
4.2.5 3-(4-(Diethylamino)but-2-ynyl)-5-(pentyloxymethyl)dihydrofuran-2(3H)-one (3e)
Yield 70%, Rf = 0.55, m.p. (oxalate salt) 93–94 °C, b.p. 170–171 °C/1 mmHg. –
4.2.6 3-(4-(Diethylamino)but-2-ynyl)-5-(butoxymethyl)dihydrofuran-2(3H)-one (3f)
Yield 78%, Rf = 0.53, m.p. (oxalate salt) 74–76 °C, b.p. 167 °C/1 mmHg. –
4.2.7 3-(4-Morpholinobut-2-ynyl)-5-(butoxymethyl)dihydrofuran-2(3H)-one (3g)
Yield 69%, Rf = 0.44, m.p. (oxalate salt) 122–124 °C, b.p. 193–194 °C/1 mmHg. –
4.2.8 3-(4-Morpholinobut-2-ynyl)-5-(propoxymethyl)dihydrofuran-2(3H)-one (3h)
Yield 62%, Rf = 0.46, m.p. (oxalate salt) 112–114 °C, b.p. 182–183 °C/1 mmHg. –
4.2.9 3-(4-(Piperidin-1-yl)but-2-ynyl)-5-(propoxymethyl)dihydrofuran-2(3H)-one (3i)
Yield 62%, Rf = 0.48, m.p. (oxalate salt) 111–112 °C, b.p. 175–176 °C/1 mmHg. –
4.2.10 3-(4-(Piperidin-1-yl)but-2-ynyl)-5-(butoxymethyl)dihydrofuran-2(3H)-one (3j)
Yield 66%, Rf = 0.42, m.p. (oxalate salt) 98–100 °C, b.p. 183–184 °C/1 mmHg. –
4.2.11 3-(4-(Dibutylamino)but-2-ynyl)-5-(butoxymethyl)-dihydrofuran-2(3H)-one (3k)
Yield 67%, Rf = 0.49, m.p. (oxalate salt) 84–86 °C, b.p. 184–185 °C/1 mmHg. –
4.2.12 3-(4-(Dibutylamino)but-2-ynyl)-5-(propoxymethyl)dihydrofuran-2(3H)-one (3l)
Yield 83%, Rf = 0.54, m.p. (oxalate salt) 78–79 °C, b.p. 179–180 °C/1 mmHg. –
Dedicated to: In memory of our dear friend and colleague Professor Vilik S. Harutyunyan.
References
[1] J. R. Woods, H. Mo, A. A. Bieberich, T. Alavanjac, D. A. Colby, Med. Chem. Commun.2013, 4, 27.10.1039/C2MD20172KSearch in Google Scholar
[2] C. Ito, M. Itoigawa, S. Katsuno, M. Omura, H. Tokuda, H. Nishino, H. Furukawa, J. Nat. Prod.2000, 63, 1218.10.1021/np990619iSearch in Google Scholar
[3] H. C. Kwon, N. I. Baek, S. U. Choi, K. R. Lee, Chem. Pharm. Bull.2000, 48, 614.10.1248/cpb.48.614Search in Google Scholar
[4] N. Agrawal, D. Pareek, S. Dobhal, M. C. Sharma, Y. C. Joshi, M. P. Dobhal, Chem. Biodiversity2013, 10, 394.10.1002/cbdv.201100300Search in Google Scholar
[5] M.-J. Cheng, T.-A. Wang, S.-J. Lee, I.-S. Chen, Nat. Prod. Res.2010, 24, 647.10.1080/14786410903098277Search in Google Scholar
[6] Z. Fang, S. Y. Jeong, H. A. Jung, J. S. Choi, B. S. Min, M. H. Woo, Chem. Pharm. Bull.2010, 58, 1236.10.1248/cpb.58.1236Search in Google Scholar
[7] H. Zhou, T. Zhu, S. Cai, Q. Gu, D. Li, Chem. Pharm. Bull.2011, 59, 762.10.1248/cpb.59.762Search in Google Scholar
[8] K. Pudhom, T. Nuanyai, K. Matsubar, Chem. Pharm. Bull.2012, 60, 1538.10.1248/cpb.c12-00699Search in Google Scholar
[9] N. P. Thao, N. H. Nam, N. X. Cuong, T. H. Quang, P. T. Tung, B. H. Tai, B. T. T. Luyen, D. Chae, S. Kim, Y.-S. Koh, P. V. Kiem, C. V. Minh, Y. H. Kim, Chem. Pharm. Bull.2012, 60, 1581.10.1248/cpb.c12-00756Search in Google Scholar
[10] D.-W. Zhang, X. Liu, D. Xie, R. Chen, X.-Y. Tao, J.-H. Zou, J. Dai, Chem. Pharm. Bull.2013, 61, 576.10.1248/cpb.c12-00987Search in Google Scholar
[11] M. J. Rieser, J. F. Koslowski, K. V. Wood, J. L. McLaughlin, Tetrahedron Lett.1991, 32, 1137.10.1016/S0040-4039(00)92027-6Search in Google Scholar
[12] T. Řezanka, M. Temina, L. Hanuš, V. M. Dembitsky, Phytochemistry2004, 65, 2605.10.1016/j.phytochem.2004.06.036Search in Google Scholar
[13] R. Singh, G. C. Singh, S. K. Ghosh, Eur. J. Org. Chem.2007, 2007, 5376.10.1002/ejoc.200700440Search in Google Scholar
[14] X. Jiang, C. Fu, S. Ma, Eur. J. Org. Chem.2010, 2010, 687.10.1002/ejoc.200901058Search in Google Scholar
[15] R. A. Fernandes, A. K. Chowdhury, Eur. J. Org. Chem.2011, 2011, 1106.10.1002/ejoc.201001419Search in Google Scholar
[16] M. Mahlau, R. A. Fernandes, R. Brückner, Eur. J. Org. Chem.2011, 4765.10.1002/ejoc.201190066Search in Google Scholar
[17] Y. Hirokawa, M. Kitamura, M. Mizubayashi, R. Nakatsuka, Y. Kobori, C. Kato, Y. Kurata, N. Maezaki, Eur. J. Org. Chem.2013, 2013, 721.10.1002/ejoc.201201247Search in Google Scholar
[18] T. Janecki, E. Błaszczyk, K. Studzian, M. Różalski, U. Krajewska, A. Janecka, J. Med. Chem.2002, 45, 1142.10.1021/jm011019vSearch in Google Scholar
[19] S. Y. Kim, J. Lee, Bioorg. Med. Chem.2004, 12, 2639.10.1016/j.bmc.2004.03.016Search in Google Scholar
[20] S. Singh, B. K. Malik, D. K. Sharma, Int. J. Integr. Biol.2007, 1, 72.Search in Google Scholar
[21] A. A. Ben-Bassat, D. Lavie, H. Edery, G. Porath, J. Med. Chem., 1976, 19, 928.10.1021/jm00229a014Search in Google Scholar
[22] R. Krattenmacher, Contraception2000, 62, 29.10.1016/S0010-7824(00)00133-5Search in Google Scholar
[23] T. V. Kochikyan, E. V. Arutyunyan, V. S. Arutyunyan, A. A. Avetisyan, Russ. J. Org. Chem.2008, 44, 1826.10.1134/S1070428008060122Search in Google Scholar
[24] T. V. Kochikyan, E. V. Arutyunyan, M. A. Samvelyan, V. S. Arutyunyan, A. A. Avetisyan, R. V. Paronikyan, H. M. Stepanyan, Pharm. Chem. J.2009, 43, 22.10.1007/s11094-009-0254-7Search in Google Scholar
[25] M. Arend, B. Westermann, N. Risch, Angew. Chem. Int. Ed.1998, 37, 1044.10.1002/(SICI)1521-3773(19980504)37:8<1044::AID-ANIE1044>3.0.CO;2-ESearch in Google Scholar
[26] M. Tramontiti, L. Angiolini, Tetrahedron1990, 46, 1791.10.1016/S0040-4020(01)89752-0Search in Google Scholar
[27] X. Jiang, D. Fu, G. Zhang, Y. Cao, L. Liu, J. Songa, R. Wang, Chem. Commun.2010, 46, 4294.10.1039/c000621aSearch in Google Scholar
[28] S. Takechi, N. Kumagai, M. Shibasaki, Org. Lett.2013, 15, 2632.10.1021/ol4008734Search in Google Scholar
[29] L. Zhou, L. Lin, J. Ji, M. Xie, X. Liu, X. Feng, Org. Lett.2011, 13, 3056.10.1021/ol200939tSearch in Google Scholar
©2016 by De Gruyter
Articles in the same Issue
- Frontmatter
- In this Issue
- Review
- Cerium intermetallics CeTX – review III
- Fusiformines A and B: new indole alkaloids from Melodinus fusiformis
- Preparation, crystal structure, thermal behavior, and theoretical studies of N,N′-dinitro-4, 4′-azo-bis(1,2,4-triazolone) (DNZTO)
- Design, synthesis, and biological evaluation of new series of 2-amido-1,3,4-thiadiazole derivatives as cytotoxic agents
- One-pot hydrothermal synthesis of H3PW12O40 supported on zeolite imidazolate frameworks (ZIF-8): a highly efficient heterogeneous catalyst for oxidation of sulfides to sulfoxides and sulfones
- Catalytic performance of a Keplerate-type, giant-ball nanoporous isopolyoxomolybdate as a highly efficient recyclable catalyst for the synthesis of biscoumarins
- Thermal behavior of benzobis(tetraethyldisilacyclobutene)
- Synthesis and crystal structures of three novel benzimidazole/benzoindolizine hybrids
- NQR and X-ray crystal structure studies of cadmium halide complexes: [C(NH2)3]CdI3 and [4-ClC6H5NH3]3CdBr5
- Phosphanchalkogenide und ihre Metallkomplexe. IV. Halogenierungsprodukte der Gold(I)halogenidkomplexe einiger Diphosphanmonochalkogenide
- Note
- Synthesis of aminomethyl derivatives of 5-substituted-3-(prop-2-ynyl)dihydrofuran-2(3H)-ones
Articles in the same Issue
- Frontmatter
- In this Issue
- Review
- Cerium intermetallics CeTX – review III
- Fusiformines A and B: new indole alkaloids from Melodinus fusiformis
- Preparation, crystal structure, thermal behavior, and theoretical studies of N,N′-dinitro-4, 4′-azo-bis(1,2,4-triazolone) (DNZTO)
- Design, synthesis, and biological evaluation of new series of 2-amido-1,3,4-thiadiazole derivatives as cytotoxic agents
- One-pot hydrothermal synthesis of H3PW12O40 supported on zeolite imidazolate frameworks (ZIF-8): a highly efficient heterogeneous catalyst for oxidation of sulfides to sulfoxides and sulfones
- Catalytic performance of a Keplerate-type, giant-ball nanoporous isopolyoxomolybdate as a highly efficient recyclable catalyst for the synthesis of biscoumarins
- Thermal behavior of benzobis(tetraethyldisilacyclobutene)
- Synthesis and crystal structures of three novel benzimidazole/benzoindolizine hybrids
- NQR and X-ray crystal structure studies of cadmium halide complexes: [C(NH2)3]CdI3 and [4-ClC6H5NH3]3CdBr5
- Phosphanchalkogenide und ihre Metallkomplexe. IV. Halogenierungsprodukte der Gold(I)halogenidkomplexe einiger Diphosphanmonochalkogenide
- Note
- Synthesis of aminomethyl derivatives of 5-substituted-3-(prop-2-ynyl)dihydrofuran-2(3H)-ones